Steward Partners Investment Advisory LLC Decreases Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Steward Partners Investment Advisory LLC trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,799 shares of the company’s stock after selling 2,057 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in GE HealthCare Technologies were worth $922,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in GEHC. Capital Performance Advisors LLP purchased a new stake in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Ashton Thomas Securities LLC purchased a new stake in shares of GE HealthCare Technologies in the third quarter worth approximately $26,000. Darwin Wealth Management LLC purchased a new stake in GE HealthCare Technologies in the third quarter worth $31,000. Continuum Advisory LLC increased its stake in GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares during the period. Finally, Bank of Jackson Hole Trust purchased a new stake in GE HealthCare Technologies in the fourth quarter worth $32,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $85.36 on Tuesday. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The company’s 50 day moving average is $86.91 and its 200 day moving average is $86.17. The firm has a market cap of $39.03 billion, a price-to-earnings ratio of 19.71, a PEG ratio of 3.19 and a beta of 1.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

GEHC has been the topic of several recent analyst reports. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup raised their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Finally, Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.